February 2024
New publication on CHIP from Stefanie Dimmeler´s laboratory in Nature Communications: Mariana Shumliakivska, a highly talented PhD student, is first author of the story entitled “DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts”. Andreas Zeiher, Wesley Abplanalp and Sebastian Cremer from HERZBLUT contributed to the study, a great joint effort!
Link
August 2024
Wesley Abplanalp chaired the session Emerging risk factors for cardiovascular diseases at the ESC Congress 2024 in London. Andreas Zeiher served as the moderator for this session.
Link
October 2024
Sameen Fatima joined the Abplanalp group as a Postdoc – welcome Sameen!
November 2024
Michael Rieger, Stefanie Dimmeler and Soni Pullamsetti with other project partners secured a highly competetive DZG Innovation Fund. This is a joint research funding program of the German Centers for Health Research (DZG). The project MetaboCHIP focuses on "Targeting the metabolic interorgan communication of ‘inflamm-aging’ – how somatic mutations drive common ageassociated diseases"
LINK
December 2024
Marius Külp, Postdoc in the Rieger Lab, received a competitive Kick-off Grant from the European Hematology Association (EHA)
January 2025
Wesley Abplanalp will be giving a talk at the ESC Heart Failure Meeting 2025 in Belgrade, Serbia, in the session Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure. His talk is entitled "Clonal hematopoiesis in ischaemic heart failure: cause or effect?".
Link
February 2025
Our HERZBLUT Retreat this year demonstrated active interaction and great productivity among all participating groups. Excellent presentations and lively discussions underscored the passion for science and collaboration in our Research Unit. As guest speakers we invited Thimoteus Speer, Director of the Nephrology Department, Goethe University Hospital, and Darja Karpova, PI at Blood Donor Service Frankfurt.